Renatus Sinkeldam, PhD, joined Dana-Farber in 2018 as a Licensing Associate. In his current role, he assists Dana-Farber investigators with all facets of technology commercialization. Prior to joining BODFI, he held various positions at the Office for Technology Management at Washington University in St. Louis, managing a diverse technology portfolio, and as a consultant at the Biotechnology and Life Science Advising Group (BALSA), working on short projects in small, diverse teams.
As a postdoctoral fellow and later a project scientist at the University of California-San Diego, Dr. Sinkeldam designed and synthesized non-perturbing fluorescent nucleosides for the study of nucleic acid structure, stability, lesions, and interactions with small molecules. He obtained his PhD from Eindhoven University of Technology, The Netherlands, completing his doctoral thesis in the areas of macro- and supra-molecular chemistry. He received his BSc and MSc degrees in Chemistry at the University of Amsterdam, The Netherlands.